210 likes | 217 Views
This systematic review/meta-analysis compares open, laparoscopic, and robotic hepatectomy to assess economic viability. Findings indicate laparoscopic resection is cost-effective, while robotic resection may be in high-volume centers.
E N D
Economic Analysis of Open Versus Laparoscopic Versus Robotic Hepatectomy: A Systematic Review and Meta-Analysis Ioannis A. Ziogas, Alexandros P. Evangeliou, Konstantinos S. Mylonas, Dimitrios I. Athanasiadis, Panagiotis Cherouveim, David A. Geller, Richard D. Schulick, Sophoclis P. Alexopoulos, Georgios Tsoulfas
Introduction • Application of minimally-invasive surgery in complex procedures (i.e. liver surgery) • International consensuses (Louisville 2008 & Morioka 2014) • Safe and efficient in appropriately selected patients • Concerns about economic viability of minimally-invasive hepatectomy
Rationale & Aim • Current reimbursement models pose a barrier in the broader adoption of minimally-invasive liver resection • Previous systematic reviews provided thorough overview of qualitative economic comparisons • No quantitative comparison (Meta-analysis) • Aim: Meta-analysis of open vs. laparoscopic vs. robotic hepatectomy to assess if minimally-invasive procedures are cost-prohibitive
Methods • PRISMA guidelines and protocol registration (reviewregistry704) • PubMed and Cochrane bibliographical databases (end-of-search date: March 16th, 2019) • Search and data extraction by 3 independent researchers and discrepancies resolved by 4th • Reference lists of included studies and previous systematic reviews hand-searched for missed studies (snowball technique)
Methods (cont.) • Quality assessment • Modified Jadad scale for randomized controlled trials (RCTs) • Newcastle–Ottawa scale (NOS) non-randomized studies • Brisbane 2000 nomenclature definition for major and minor liver resections (Morioka 2014) • Minor: 2 Couinaud segments • Major: 3 Couinaud segments • Cost in variable units (United States Dollar [USD], Euro, Chinese Yuan, etc.) • all units into USD as per official exchange rates publicly available at the time each individual study was conducted
Methods (cont.) • Meta-analyses of operative, hospitalization, and total economic costs: • OLR vs. LLR • LLR vs. robotic liver resection [RLR] • OLR vs. RLR • Subgroup analyses: (i) major hepatectomy series, and (ii) minor hepatectomy series • Cochran Q statistic and by estimating I2: between-study heterogeneity • Sensitivity analyses: origin of potential heterogeneity • Funnel plots and the Egger’s formal statistical test: publication bias
Results • 28 eligible studies • 2 RCTs • 26 non-randomized (3 prospective, 23 retrospective) • Quality assessment • Modified Jadad scale: 4.5 ± 2.1 • NOS: 7.8 ± 0.7
1. Open vs. Laparoscopic A) Operative costs
1. Open vs. Laparoscopic B) Hospitalization costs
1. Open vs. Laparoscopic C) Total costs
2. Laparoscopic vs. Robotic • Operative & B) Hospitalization costs • Paucity of data C) Total costs
3. Open vs. Robotic • Lack of data no economic meta-analysis • Qualitative synthesis (4 studies comparing OLR vs. RLR): A) Operative costs: OLR < RLR B) Hospitalization costs: OLR > RLR C) Total costs: OLR ≃ RLR (mixed results, East vs. West re-imbursement models) • Quality of life: OLR < RLR
Additional costs of the robot • Fixed capital costs ($2,600,000) • Longevity ~ 10 years • 2,600,000 ➗ 10 = $260,000 per annum • Annual maintenance costs ($175,000) • Total ~ $435,000 annual costs just for the robot • If high-volume center (2 cases/day 500/year): $870 per case • If low-volume center (2 cases/week 100/year): $4,350 per case
Limitations • Only two RCTs • Confounders (institutions’/surgeons’ experience) impossible to evaluate • Differences in economic costs over the years (patients operated on from 1997 to 2017), and among countries (Eastern versus Western countries) • Lack of either SD or other measures of variance were not reported (18/28 studies in meta-analysis) • Paucity of economic data regarding the comparison of open and robotic hepatectomy
Conclusions • Laparoscopic Hepatectomy • Major: total costs OLR ≃ LLR • Minor: total costs OLR > LLR • Not cost-prohibitive • Robotic Hepatectomy • Total costs: RLR > LLR and RLR > OLR • Not cost prohibitive only in high-volume institutions • Future well-powered RCTs are needed (awaiting results of The ORANGE II PLUS - Trial [NCT01441856]) • Greater experience overcome learning curve decrease in operative time and instrumentation use better economic profiles